These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 16648553)
21. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression. Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062 [TBL] [Abstract][Full Text] [Related]
22. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer. Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522 [TBL] [Abstract][Full Text] [Related]
23. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells. Chou CC; Chuang HC; Salunke SB; Kulp SK; Chen CS Oncotarget; 2015 Apr; 6(10):8271-85. PubMed ID: 25821081 [TBL] [Abstract][Full Text] [Related]
24. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma. Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724 [TBL] [Abstract][Full Text] [Related]
25. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells. Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114 [TBL] [Abstract][Full Text] [Related]
26. α-Catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis. Liang CH; Chiu SY; Hsu IL; Wu YY; Tsai YT; Ke JY; Pan SH; Hsu YC; Li KC; Yang PC; Chen YL; Hong TM Cancer Res; 2013 Jan; 73(1):428-38. PubMed ID: 23047866 [TBL] [Abstract][Full Text] [Related]
27. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. Zhu J; Pan X; Zhang Z; Gao J; Zhang L; Chen J Cell Signal; 2012 Jun; 24(6):1323-32. PubMed ID: 22570869 [TBL] [Abstract][Full Text] [Related]
28. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Lin SW; Ke FC; Hsiao PW; Lee PP; Lee MT; Hwang JJ Exp Cell Res; 2007 Feb; 313(3):602-13. PubMed ID: 17187779 [TBL] [Abstract][Full Text] [Related]
29. Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma. Han KS; Li N; Raven PA; Fazli L; Ettinger S; Hong SJ; Gleave ME; So AI Mol Cancer Ther; 2015 Apr; 14(4):1024-34. PubMed ID: 25657336 [TBL] [Abstract][Full Text] [Related]
30. ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo. Rosanò L; Di Castro V; Spinella F; Nicotra MR; Natali PG; Bagnato A Mol Cancer Ther; 2007 Jul; 6(7):2003-11. PubMed ID: 17620430 [TBL] [Abstract][Full Text] [Related]
31. Endothelin-1 decreases gap junctional intercellular communication by inducing phosphorylation of connexin 43 in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A J Biol Chem; 2003 Oct; 278(42):41294-301. PubMed ID: 12907686 [TBL] [Abstract][Full Text] [Related]
32. Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells. Rayhman O; Klipper E; Muller L; Davidson B; Reich R; Meidan R Cancer Res; 2008 Nov; 68(22):9265-73. PubMed ID: 19010899 [TBL] [Abstract][Full Text] [Related]
33. Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation. Del Bufalo D; Di Castro V; Biroccio A; Varmi M; Salani D; Rosanò L; Trisciuoglio D; Spinella F; Bagnato A Mol Pharmacol; 2002 Mar; 61(3):524-32. PubMed ID: 11854432 [TBL] [Abstract][Full Text] [Related]
34. Integrin-linked kinase in gastric cancer cell attachment, invasion and tumor growth. Zhao G; Guo LL; Xu JY; Yang H; Huang MX; Xiao G World J Gastroenterol; 2011 Aug; 17(30):3487-96. PubMed ID: 21941415 [TBL] [Abstract][Full Text] [Related]
35. Effects of lentivirus-mediated shRNA targeting integrin-linked kinase on oral squamous cell carcinoma in vitro and in vivo. Que L; Zhao D; Tang XF; Liu JY; Zhang XY; Zhan YH; Zhang L Oncol Rep; 2016 Jan; 35(1):89-98. PubMed ID: 26531674 [TBL] [Abstract][Full Text] [Related]
36. Emerging role of the endothelin axis in ovarian tumor progression. Bagnato A; Spinella F; Rosanò L Endocr Relat Cancer; 2005 Dec; 12(4):761-72. PubMed ID: 16322321 [TBL] [Abstract][Full Text] [Related]
37. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer. Mongroo PS; Johnstone CN; Naruszewicz I; Leung-Hagesteijn C; Sung RK; Carnio L; Rustgi AK; Hannigan GE Oncogene; 2004 Nov; 23(55):8959-70. PubMed ID: 15467740 [TBL] [Abstract][Full Text] [Related]
38. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy. Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819 [TBL] [Abstract][Full Text] [Related]
39. The endothelin A receptor and epidermal growth factor receptor signaling converge on β-catenin to promote ovarian cancer metastasis. Cianfrocca R; Tocci P; Spinella F; Di Castro V; Bagnato A; Rosanò L Life Sci; 2012 Oct; 91(13-14):550-6. PubMed ID: 22480520 [TBL] [Abstract][Full Text] [Related]
40. Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription. Lössner D; Abou-Ajram C; Benge A; Aumercier M; Schmitt M; Reuning U J Cell Physiol; 2009 Aug; 220(2):367-75. PubMed ID: 19334037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]